The table below shows COGNITION THERAPEUTICS INC's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$24.59M
-$28.47M
-$16.02M
-$18.53M
-$3.63M
-$3.43M
Capital expenditure
-
$4.00K
$147.00K
$171.00K
$27.00K
$10.00K
Investing cash flow
$9.00K
-$4.00K
-$147.00K
-$171.00K
-$27.00K
-$10.00K
Dividends paid
-
-
-
-
CGTX operating cash flow (10-K history)
COGNITION THERAPEUTICS INC reported operating cash flow of -$24.59M for fiscal year 2025. That is up 13.6% from -$28.47M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow declined from -$3.43M (FY 2020) to -$24.59M. Figures come from the company's audited annual reports as filed with the SEC.